The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and varying degrees of necroinflammation. Although chronic oxidative stress, inflammatory cytokines, and insulin resistance have been implicated in the pathogenesis of NAFLD, the mechanisms that underlie the initiation and progression of this disease remain unknown. c-Jun N-terminal kinase (JNK) is activated by oxidants and cytokines and regulates hepatocellular injury and insulin resistance, suggesting that this kinase may mediate the development of steatohepatitis. The presence and function of JNK activation were therefore examined in the murine methionine- and choline-deficient (MCD) diet model of steatohepatitis. Activation of hepatic JNK, c-Jun, and AP-1 signaling occurred in parallel with the development of steatohepatitis in MCD diet-fed mice. Investigations in jnk1 and jnk2 knockout mice demonstrated that jnk1, but not jnk2, was critical for MCD diet-induced JNK activation. JNK promoted the development of steatohepatitis as MCD diet-fed jnk1 null mice had significantly reduced levels of hepatic triglyceride accumulation, inflammation, lipid peroxidation, liver injury, and apoptosis compared with wild-type and jnk2 -/- mice. Ablation of jnk1 led to an increase in serum adiponectin but had no effect on serum levels of tumor necrosis factor-alpha. In conclusion, JNK1 is responsible for JNK activation that promotes the development of steatohepatitis in the MCD diet model. These findings also provide additional support for the critical mechanistic involvement of JNK1 overactivation in conditions associated with insulin resistance and the metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, activation of JNK was positively related to high fat diet-induced insulin resistance and metabolic syndrome [119], [121], [122], [123].”
In the citing paper
“Furthermore, persistent activation of JNK and/or p38K is positively associated with various liver diseases such as steatohepatitis and I/R injury [122], [123], [124], [125], suggesting the clinical importance of JNK and p38K in human disease states, as reviewed [126].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,728
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,312
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–382 of 382
Acidophil bodies in nonalcoholic steatohepatitis
Yeh, M. M., Belt, P. H., Brunt, E. M., Kowdley, K. V., Wilson, L., & Ferrell, L. D. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.01.001 · Cited by 10
Non-alcoholic Fatty Liver Disease
Smolle, E., Kessler, S. M., Golob, N., & Haybaeck, J. (2015) · Springer eBooks · doi:10.1007/978-3-319-11251-0_36 · Cited by 10
Tan, J. H., Gao, W., Yang, W., Zeng, X., Wang, L., & Cui, X. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.03.083 · Cited by 9
Mechanisms underlying fat-induced hepatic insulin resistaNce
Park, E., & Giacca, A. (2007) · Future Lipidology · doi:10.2217/17460875.2.5.503 · Cited by 9
Oxidative Stress and Liver Injury
Cubero, F. J., & Trautwein, C. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_28 · Cited by 9
Mobasher, M. A., & Valverde, Á. M. (2014) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2014.893365 · Cited by 9
Kwak, D. H., Kim, J. S., Chang, K.-T., & Choo, Y. (2016) · Journal of Veterinary Science · doi:10.4142/jvs.2016.17.3.279 · Cited by 9
Bae, U., Oh, M., Park, J., Park, J., Bae, E.-Y., Chae, S., Cho, B. H., & Park, B. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.01.032 · Cited by 9
Wang, Y., Sun, K., Liu, Y., Lu, Y., Feng, D., & Qi, H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106165 · Cited by 8
Bidooki, S. H., Barranquero, C., Sánchez-Marco, J., Martínez‐Beamonte, R., Rodriguez‐Yoldi, M. J., Navarro, M. Á., Fernandes, S. C. M., & Osada, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137128 · Cited by 9
CYP2E1, oxidative stress and MAPK signaling pathways in alcohol-induced hepatotoxicity
Yang, L., Wu, D., & Cederbaum, A. I. (2014) · Cited by 8
Pathogenesis of NAFLD and NASH
Maher, J. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_4 · Cited by 8
NPFFR2-deficient mice fed a high-fat diet develop strong intolerance to glucose
Karnošová, A., Strnadová, V., Železná, B., Kuneš, J., Kašpárek, P., & Maletı́nská, L. (2023) · Clinical Science · doi:10.1042/cs20220880 · Cited by 8
Teucrium polium reversed the MCD diet-induced liver injury in rats
Amini, R., Yazdanparast, R., Aghazadeh, S., & Ghaffari, S. H. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327110388961 · Cited by 8
Gehrke, N., Hofmann, L. J., Straub, B. K., Ridder, D. A., Waisman, A., Kaps, L., Galle, P. R., & Schattenberg, J. M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000568 · Cited by 7
Non-Alcoholic Fatty Steatohepatitis an Inflammatory Disorder Beyond the Liver
Cerpa‐Cruz, S. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000159 · Cited by 6
Solinas, P., Isola, M., Lilliu, M. A., Conti, G., Civolani, A., Demelia, L., Loy, F., & Isola, R. (2014) · Microscopy Research and Technique · doi:10.1002/jemt.22401 · Cited by 6
MLK 3 as a regulator of disease progression in Non‐alcoholic steatohepatitis
Jiang, J. X., & Torok, N. J. (2014) · Liver International · doi:10.1111/liv.12556 · Cited by 6
C-Jun Nh2-Terminal Kinase 1 in Hepatocytes: An Essential Mediator of Insulin Resistance
Cubero, F. J., Drvarov, O., & Trautwein, C. (2010) · Hepatology · doi:10.1002/hep.23737 · Cited by 5
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Cazanave, S. C., & Sanyal, A. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-25065-6_5 · Cited by 5
Cederbaum, A. I. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0092-0 · Cited by 5
Oxidative stress and apoptosis in hepatitis C: the core issue
Koike, K. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1786-1 · Cited by 5
Yang, H., Zhang, C., Kim, W., Shi, M., Kılıçlıoğlu, M., Bayram, C., Bolat, İ., Tozlu, Ö. Ö., Baba, C., Yuksel, N., et al. (2024) · eLife · doi:10.7554/elife.98427 · Cited by 5
Takaki, A., Uchida, D., & Yamamoto, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00012-6 · Cited by 1
Mandrekar, P., & Szabó, G. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_27 · Cited by 3
Apoptosis in Liver Injury and Liver Diseases
Osawa, Y., Seki, E., & Brenner, D. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_24 · Cited by 3
Cellular Signaling Pathways in Alcoholic Liver Disease
Mandrekar, P., & Ambade, A. (2012) · InTech eBooks · doi:10.5772/27412 · Cited by 3
The forkhead box O family in insulin action and lipid metabolism
Lee, S., Zhu, C., Yamauchi, J., Zhu, P., Feng, X., Qu, S., & Dong, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00013-0 · Cited by 3
Valente, L. C., Riechelmann-Casarin, L., Otton, R., Delella, F. K., Barbisan, L. F., & Romualdo, G. R. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.04.009 · Cited by 3
A Panel of Protein Kinase Chemosensors Distinguishes Different Types of Fatty Liver Disease
Beck, J. R., Cabral, F., Rasineni, K., Casey, C. A., Harris, E. N., & Stains, C. I. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00547 · Cited by 3
Cytochrome P4502E1, Oxidative Stress, JNK, and Autophagy in Acute Alcohol-Induced Fatty Liver
Cederbaum, A. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-405877-4.00024-x · Cited by 3
Advances in Alcoholic Liver Disease
Osna, N. A., Kharbanda, K. K., Schrum, L. W., & Dolganiuc, A. (2012) · International Journal of Hepatology · doi:10.1155/2012/563018 · Cited by 3
Chew, C.-H., Ng, D.-L., Tie, S.-W., Ong, P.-C., Lim, W.-S., Muhammad, T. S. T., & Choo, Q.-C. (2011) · Electronic Journal of Biotechnology · doi:10.2225/vol14-issue3-fulltext-9 · Cited by 3
Kinase-dependent pathways and the development of insulin resistance in hepatocytes
Rondinone, C. M. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.2.195 · Cited by 4
Sharma, A., Hakkak, R., Gökden, N., Joshi, N., & Parajuli, N. (2025) · Nutrients · doi:10.3390/nu17132115 · Cited by 2
Geyvandova, N. I., Morozov, V. G., Zaitsev, M. Y., Sardaryan, I. S., Черногорова, М. В., Belikova, T. N., & Карева, Е. Н. (2025) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro20251403171 · Cited by 2
Martínez, G., & Ángel, M. (2012) · Congreso de los Diputados eBooks · Cited by 2
Liver and biliary tract disorders
Moseley, R. H. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000218954.17570.06 · Cited by 2
Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma
Villarruel-Melquiades, F., Aguirre-Maldonado, I., Herrera-López, E. E., Mendoza‐Garrido, M. E., Pérez‐Carreón, J. I., Bañuelos, C., & Camacho, J. (2024) · Hepatoma Research · doi:10.20517/2394-5079.2024.95 · Cited by 2
Yang, H., Zhang, C., Kim, W., Shi, M., Kılıçlıoğlu, M., Bayram, C., Bolar, I., Tozlu, Ö. Ö., Baba, C., Yuksel, N., et al. (2024) · eLife · doi:10.7554/elife.98427.3 · Cited by 8
Theodorou, R.-E., Vrettos, N., & Theodosis‐Nobelos, P. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050465 · Cited by 1
Exercise, Liver Steatosis, and Free Radicals
Gonçalves, I. O., Martins, M. J., Beleza, J., Ascensão, A. A. M. R., & Magalhães, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00024-2 · Cited by 1
Pagano, S., Somm, E., Juillard, C., Liaudet, N., Ino, F., Ferrari, J., Braunersreuther, V., Jornayvaz, F. R., & Vuilleumier, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211875 · Cited by 1
Molecular Basis of Liver Disease
Monga, S. P., & Behari, J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00020-2 · Cited by 1
OBESITY AND TYPE 3 DIABETES: NUTRITIONAL APPROACHES AND THERAPEUTIC IMPLICATION
Sakr, A. (2019) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2019.10144.1023 · Cited by 1
Schattenberg, J. M. (2009) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s3497 · Cited by 1
Schwabe, R. F. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_14 · Cited by 1
TXNIP in liver sinusoidal endothelial cells ameliorates alcohol-associated liver diseasePreprint
Jung, E., Baek, E. B., Hong, E.-J., Kang, J. H., Park, S., Hong, E., Cho, Y., Ko, J., Won, Y., & Kwon, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.30.526192 · Cited by 1
Mitogen-activated Protein Kinase Phosphatases in Inflammation and as Anti-inflammatory Drug Targets
Hömmö, T. (2014) · Tampere University Institutional Repository (Tampere University)
Non-alcoholic fatty liver disease: an emerging liver disease
Söderberg, C. (2011) · Figshare
Studies on the mechanisms of action and physiological relevance of SOCS proteins
Zadjali, F. (2011) · Figshare
c‐Jun NH 2 ‐terminal kinases in liver diseases
Kluwe, J., & Schwabe, R. F. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch25
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease
Kowalik, M. A. (2009) · VEprints - Universita degli Studi di Cagliari
Feng, T. T. Q. (2012) · TSpace (University of Toronto)
pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Liu, Q., Bengmark, S., & Qu, S. (2010)
Manco, M., Putignani, L., & Bottazzo, G. F. (2010)
Mendoza, P. G. L., Tsui, W. M. S., Ho, L., Wayne, M. G., Kagen, A., & Theise, N. D. (2016) · Philippine Journal of Pathology · doi:10.21141/pjp.2016.008
Mechanisms of Liver Cell Destruction
Malhi, H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00003-6
Kiràly, M. A. (2008) · TSpace (University of Toronto)
Linking Endoplasmic Reticulum Stress to Cell Death in Hepatocytes: Roles of C/EBP Homologous
Pfaffenbach, K. T., Gentile, C. L., Nivala, A. M., Wang, D., Wei, Y., & Pagliassotti, M. J. (2010)
Proteomics of lipid accumulation and DGAT inhibition in HepG2 liver carcinoma cells
Bhatt-Wessel, B. (2017) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17058194
Maradana, M. R. (2016) · The University of Queensland · doi:10.14264/uql.2016.1080
Jung, T. W., Kim, S., Kim, D., Shin, E., Park, Y. B., & Lee, K. (2018) · Pharmacology · doi:10.1159/000487892
Xu, E. (2012) · Corpus Université Laval (Université Laval)
Pathogenic Mechanism of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
Kim, S. M., & Sohn, J. H. (2014) · Journal of Liver Cancer · doi:10.17998/jlc.14.2.63
Rouini, N. (2021)
Behari, J. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_29
Molecular Basis of Liver Disease
Monga, S. P., & Behari, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00020-1
Treatment and Exploration of Non-Alcoholic Fatty Liver Disease in Traditional Chinese Medicine
(2022) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2022.04(06).21
Pathopysiologie: Insulinresistenz
Kluwe, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_6
karawia, Z., & Mansour, M. A. (2023) · Zagazig Veterinary Journal/Zagazig Veterinary Journal (Online) · doi:10.21608/zvjz.2023.192324.1207
Yang, H., Zhang, C., Kim, W., Shi, M., Kılıçlıoğlu, M., Bayram, C., Bolat, İ., Tozlu, Ö. Ö., Baba, C., Yuksel, N., et al. (2024) · eLife · doi:10.7554/elife.98427.1
Yang, H., Zhang, C., Kim, W., Shi, M., Kılıçlıoğlu, M., Bayram, C., Bolat, İ., Tozlu, Ö. Ö., Baba, C., Yuksel, N., et al. (2025) · eLife · doi:10.7554/elife.98427.2 · Cited by 1
Lésions hépatiques induites par l'ischémie reperfusion et la NAFLD : mécanismes et protection
Iannelli, A. (2010) · theses.fr (ABES) · doi:10.70675/701458fczea0az4a7az8d86z08f08e5f71fc
The roles of endoplasmic reticulum stress and Bax inhibitor-1 in non-alcoholic fatty liver disease
Lebeaupin, C. (2018) · theses.fr (ABES) · doi:10.70675/de500ab2z3c59z484dz8f58z7c3173626c42
Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
Smati, S. (2019) · theses.fr (ABES) · doi:10.70675/01997f55za990z41e6z96baz8221de2a6281
Karunakara, S. H., & Santhekadur, P. K. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153846
Wu, Y., Chen, S., Chen, Y., Yu, Q., Li, J., Pan, Y., & Zhou, L. (2026) · Food & Function · doi:10.1039/d6fo02892f
De la stéatohépatite non alcoolique au carcinome hépatocellulaire : mécanismes physiopathologiques
Desbois‐Mouthon, C. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70184-5
Metadata
- Authors
- Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J.
- Affiliations
- Albert Einstein College of Medicine (US)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Czaja, Mark J.
- Venue
- Hepatology
- Published
- 2006-01
- Volume
- 43
- Issue
- 1
- Pages
- 163-172
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2108678340
- Cited by
- 384
- References
- 43
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 14 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 18 · 2019: 11 · 2018: 14 · 2017: 21 · 2016: 18 · 2015: 20 · 2014: 29 · 2013: 24 · 2012: 26
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-61498, DK 55758, R01DK055758, R01DK061498)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- JNK1, JNK2, non-alcoholic fatty liver disease, steatohepatitis, methionine-choline-deficient diet, hepatic steatosis, c-Jun, AP-1 signaling, lipid peroxidation, liver inflammation, insulin resistance, adiponectin, TNF-α, apoptosis, knockout mice
- MeSH terms
- Alanine Transaminase, Animals, Choline Deficiency, Enzyme Activation, Fatty Liver, Female, Liver, Male, Methionine, Mice, Inbred C57BL, Triglycerides, Lipid Peroxidation, Apoptosis, Intercellular Adhesion Molecule-1, Mitogen-Activated Protein Kinase 8, Mitogen-Activated Protein Kinase 9, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review